Exhibit 32.1

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of China Biopharmaceuticals Holdings,
Inc. (the "Company") on Form 10-Q for the quarter ending September 30, 2008 as
filed with the Securities and Exchange Commission on the date hereof (the
"Report"), each of the undersigned, in the capacities and on the date indicated
below, hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant
to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:

1)   The report fully complies with the requirements of Section 13(a) or 15(d)
     of the Securities Exchange Act of 1934; and

2)   The information contained in the Report fairly presents, in all material
     respects, the financial condition and results of operations of the Company.


                                                 /s/ Chris Peng Mao
                                                 ------------------
                                                 Chris Peng Mao
                                                 Chief Executive Officer
                                                 November 14, 2008